Tafamidis Completed Phase 3 Trials for Osteoarthritis of the Knee Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03046446Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee
NCT02357459Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
NCT03529942Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee